» Articles » PMID: 24943896

Hydroxybenzoic Acid Isomers and the Cardiovascular System

Overview
Journal Nutr J
Publisher Biomed Central
Date 2014 Jun 20
PMID 24943896
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Today we are beginning to understand how phytochemicals can influence metabolism, cellular signaling and gene expression. The hydroxybenzoic acids are related to salicylic acid and salicin, the first compounds isolated that have a pharmacological activity. In this review we examine how a number of hydroxyphenolics have the potential to ameliorate cardiovascular problems related to aging such as hypertension, atherosclerosis and dyslipidemia. The compounds focused upon include 2,3-dihydroxybenzoic acid (Pyrocatechuic acid), 2,5-dihydroxybenzoic acid (Gentisic acid), 3,4-dihydroxybenzoic acid (Protocatechuic acid), 3,5-dihydroxybenzoic acid (α-Resorcylic acid) and 3-monohydroxybenzoic acid. The latter two compounds activate the hydroxycarboxylic acid receptors with a consequence there is a reduction in adipocyte lipolysis with potential improvements of blood lipid profiles. Several of the other compounds can activate the Nrf2 signaling pathway that increases the expression of antioxidant enzymes, thereby decreasing oxidative stress and associated problems such as endothelial dysfunction that leads to hypertension as well as decreasing generalized inflammation that can lead to problems such as atherosclerosis. It has been known for many years that increased consumption of fruits and vegetables promotes health. We are beginning to understand how specific phytochemicals are responsible for such therapeutic effects. Hippocrates' dictum of 'Let food be your medicine and medicine your food' can now be experimentally tested and the results of such experiments will enhance the ability of nutritionists to devise specific health-promoting diets.

Citing Articles

In vivo Differential Effects of Extractable and Non-Extractable Phenolic Compounds from Grape Pomace on the Regulation of Obesity and Associated Metabolic Alterations.

Servin-Uribe R, Castilla-Ramirez P, Ramirez I, Jimenez J, Reynoso-Camacho R Plant Foods Hum Nutr. 2025; 80(1):37.

PMID: 39821690 DOI: 10.1007/s11130-024-01278-4.


Enhancement Strategy for Protocatechuic Acid Production Using with Focus on Continuous Fermentation Scale-Up and Cytotoxicity Management.

Chung J, Shin W, Park C, Cho J Int J Mol Sci. 2025; 26(1.

PMID: 39796251 PMC: 11720217. DOI: 10.3390/ijms26010396.


Polyphenols: From Classification to Therapeutic Potential and Bioavailability.

Ciupei D, Colisar A, Leopold L, Stanila A, Diaconeasa Z Foods. 2025; 13(24.

PMID: 39767073 PMC: 11675957. DOI: 10.3390/foods13244131.


Camellia sinensis methanolic leaves extract: Phytochemical analysis and anticancer activity against human liver cancer cells.

Hanna D, Al-Atmani A, AlRashidi A, Shafee E PLoS One. 2024; 19(11):e0309795.

PMID: 39541389 PMC: 11563400. DOI: 10.1371/journal.pone.0309795.


From Stem to Spectrum: Phytochemical Characterization of Five Species and Evaluation of Their Antioxidant Potential.

Gazafroudi K, Mailander L, Daniels R, Kammerer D, Stintzing F Molecules. 2024; 29(12).

PMID: 38930889 PMC: 11206348. DOI: 10.3390/molecules29122821.


References
1.
Zadernowski R, Naczk M, Nesterowicz J . Phenolic acid profiles in some small berries. J Agric Food Chem. 2005; 53(6):2118-24. DOI: 10.1021/jf040411p. View

2.
Latocha P, Krupa T, Wolosiak R, Worobiej E, Wilczak J . Antioxidant activity and chemical difference in fruit of different Actinidia sp. Int J Food Sci Nutr. 2010; 61(4):381-94. DOI: 10.3109/09637480903517788. View

3.
Sroka Z, Cisowski W . Hydrogen peroxide scavenging, antioxidant and anti-radical activity of some phenolic acids. Food Chem Toxicol. 2003; 41(6):753-8. DOI: 10.1016/s0278-6915(02)00329-0. View

4.
Yeh C, Yen G . Induction of hepatic antioxidant enzymes by phenolic acids in rats is accompanied by increased levels of multidrug resistance-associated protein 3 mRNA expression. J Nutr. 2005; 136(1):11-5. DOI: 10.1093/jn/136.1.11. View

5.
Juurlink B . Therapeutic potential of dietary phase 2 enzyme inducers in ameliorating diseases that have an underlying inflammatory component. Can J Physiol Pharmacol. 2001; 79(3):266-82. View